Skip to main content

About Institut Pasteur de Dakar

Created in 1924, Institut Pasteur de Dakar works to accelerate equitable, sustainable and affordable access to health in Africa. As a Senegalese not-for-profit foundation recognized as being of public utility, IPD provides communities with healthcare solutions and laboratory services, engages in cutting-edge biomedical research and innovation, manufactures vaccines and diagnostics essential to African populations, develops human capital, and engages in public health activities such as epidemic intelligence, outbreak response, and surveillance.

Why this Forum?

The Institut Pasteur de Dakar (IPD) is convening its first Strategic Partners Forum, a platform for in-depth consultation, trusted exchange, and programmatic co-creation with its closest institutional partners. Under the leadership of its new CEO, Dr. Socé FALL, IPD will present its Integrated Business Plan and Investment Case 2026–2030.

Strengthen relationships

Deepen ties between IPD and its most influential strategic partners across the globe.

Share progress & insights

Share progress, lessons, and innovations from surveillance, R&D, and biomanufacturing programmes.

Mobilise commitments

Secure technical, strategic, and financial commitments to support global health security.

Launch a Partners Council

Formalise the establishment of the IPD Partners and Investors Council for lasting coordination.

African Health Sovereignty

Innovation · Talent · Resilient Institutions

11–13 June 2026